Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Assets (2016 - 2025)

Historic Current Assets for Adma Biologics (ADMA) over the last 14 years, with Q3 2025 value amounting to $402.7 million.

  • Adma Biologics' Current Assets rose 2654.43% to $402.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.7 million, marking a year-over-year increase of 2654.43%. This contributed to the annual value of $331.4 million for FY2024, which is 2894.68% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Current Assets is $402.7 million, which was up 2654.43% from $399.6 million recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Current Assets peaked at $402.7 million during Q3 2025, and registered a low of $171.4 million during Q2 2021.
  • For the 5-year period, Adma Biologics' Current Assets averaged around $270.2 million, with its median value being $266.2 million (2023).
  • Per our database at Business Quant, Adma Biologics' Current Assets surged by 3576.73% in 2021 and then tumbled by 495.15% in 2023.
  • Over the past 5 years, Adma Biologics' Current Assets (Quarter) stood at $208.7 million in 2021, then increased by 29.55% to $270.4 million in 2022, then fell by 4.95% to $257.0 million in 2023, then grew by 28.95% to $331.4 million in 2024, then grew by 21.5% to $402.7 million in 2025.
  • Its Current Assets was $402.7 million in Q3 2025, compared to $399.6 million in Q2 2025 and $351.8 million in Q1 2025.